Loading clinical trials...

Evaluation of Bone Architecture and Bone Strength in Adults With Hypophosphatasia (HPP) | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT04181164

Evaluation of Bone Architecture and Bone Strength in Adults With Hypophosphatasia (HPP)

The study aims to evaluate the bone architecture and bone strength in adults with Hypophosphatasia (HPP).

Lead sponsor: Hvidovre University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1/2

A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1

NCT07179640 · Hypophosphatasia (HPP)

COMPLETEDPhase 2

Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)

NCT00952484 · Hypophosphatasia (HPP)

COMPLETED

A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)

NCT01419028 · Hypophosphatasia (HPP)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 1, 2021Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment30

Start dateOct 2019

Last updatedSep 1, 2021

Condition

Hypophosphatasia (HPP)

Locations shown

Hvidovre University Hospital

Hvidovre, Capital Region

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 1, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions